NCT02085915

Brief Summary

The forecast of the spontaneous infection of the liquid of ascites (ISLA) at the cirrhotic patient is still burdened by a heavy mortality. The fast diagnosis of the ISLA is thus an essential stake to improve the forecast. Investigators would so like to estimate the interest of the strip PeriScreen for the fast diagnosis of the ISLA at cirrhotic patients . Investigators plan to include 670 patients, what would allow to make out a will at least on ascites 2000 on about twenty centers for duration estimated of 12 months.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
649

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2014

Geographic Reach
2 countries

22 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 7, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 13, 2014

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
10.7 years until next milestone

Results Posted

Study results publicly available

May 5, 2026

Completed
Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

1.4 years

First QC Date

March 7, 2014

Results QC Date

October 1, 2025

Last Update Submit

April 14, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sensitivity and Specificity

    Comparaison of Periscreen strip whith "Trace" threshold to the cytological analysis,

    Baseline

Study Arms (1)

strip Peri Screen

OTHER
Other: strip Peri Screen

Interventions

strip Peri Screen

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female over 18 years
  • Presence of ascites due to cirrhosis
  • Hospitalization for a complication of cirrhosis (ascites first decompensation, gastrointestinal bleeding, encephalopathy, etc ...).
  • Hospitalization to perform a paracentesis evacuated outpatient
  • Patients on long-term antibiotic primary or secondary prophylaxis the spontaneous bacterial peritonitis and with clinical and/or biological signs that suggest spontaneous infection of ascite.

You may not qualify if:

  • Patients with ascites urgently admitted to hospital for suspected infection receiving antibiotics for more than 12 hours.
  • chylous ascites,
  • Hemorrhagic Ascites
  • Biliary Ascites (straw)
  • Ascites heterogeneous appearance
  • Ascites not related to portal hypertension (peritoneal carcinomatosis, pancreatic ascites, tuberculosis, etc ...)
  • Patient receiving imipenem IV.
  • Patients on long-term antibiotic primary or secondary prophylaxis the spontaneous bacterial peritonitis without clinical and/or biological signs that suggest spontaneous infection of ascite.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (22)

Hopital Jolimont

Haine-Saint-Paul, B-7100, Belgium

Location

CH Amiens

Amiens, 80054, France

Location

CHU Besançon

Besançon, 25000, France

Location

CHRU de Brest

Brest, 29200, France

Location

CH Caen

Caen, 14033, France

Location

CH Cholet

Cholet, 49300, France

Location

Hopîtal Beaujon

Clichy, 92118, France

Location

Hopital Laennec

Creil, 60109, France

Location

CH Dijon

Dijon, 21034, France

Location

CH Gonesse

Gonesse, 95300, France

Location

CHD Vendée

La Roche-sur-Yon, 85925, France

Location

CH Lille

Lille, 59037, France

Location

CHU Nice

Nice, 06200, France

Location

CH Orléans

Orléans, 45067, France

Location

CH Reims

Reims, 51092, France

Location

CH Rennes

Rennes, 35000, France

Location

CH Rouen

Rouen, 76031, France

Location

CH St Antoine

Saint-Antoine, 75571, France

Location

CH Yves Le Foll

Saint-Brieuc, 22027, France

Location

CH Saint-Denis - Hôpital de la Fontaine

Saint-Denis, 93205, France

Location

Hôpital Purpan

Toulouse, 31059, France

Location

CH Vannes

Vannes, 56017, France

Location

Related Publications (1)

  • Thevenot T, Briot C, Mace V, Lison H, Elkrief L, Heurgue-Berlot A, Bureau C, Jezequel C, Riachi G, Louvet A, Pauwels A, Ollivier-Hourmand I, Anty R, Carbonell N, Labadie H, Aziz K, Grasset D, Nguyen-Khac E, Kaassis M, Hermann S, Tanne F, Mouillot T, Roux O, Le Thuaut A, Cervoni JP, Cadranel JF, Schnee M; CFEHTP, ANGH and the PerDRISLA study group. The Periscreen Strip Is Highly Efficient for the Exclusion of Spontaneous Bacterial Peritonitis in Cirrhotic Outpatients. Am J Gastroenterol. 2016 Oct;111(10):1402-1409. doi: 10.1038/ajg.2016.344. Epub 2016 Sep 13.

MeSH Terms

Conditions

FibrosisInfections

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr Matthieu SCHNEE
Organization
Centre hospitalier départemental Vendée

Study Officials

  • Matthieu SCHNEE, Dr

    CHD Vendée La Roche sur Yon

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2014

First Posted

March 13, 2014

Study Start

March 1, 2014

Primary Completion

August 1, 2015

Study Completion

September 1, 2015

Last Updated

May 5, 2026

Results First Posted

May 5, 2026

Record last verified: 2026-04

Locations